Literature DB >> 15571819

Ubiquitin, proteasome and parkin.

Keiji Tanaka1, Toshiaki Suzuki, Nobutaka Hattori, Yoshikuni Mizuno.   

Abstract

The ubiquitin-proteasome system (UPS) is important for intracellular proteolysis, and is responsible for a diverse array of biologically important cellular processes, such as cell-cycle progression, signaling cascades and developmental programs. This system is also involved in the protein quality control, which maintains the health of the cell. Thus, the UPS provides a clue for understanding of the molecular mechanisms underlying various neurodegenerative diseases. In the last decade, we witnessed a tremendous progress in uncovering the mechanisms of Parkinson's disease (PD). Of the several genes that can cause familial PD, parkin, the causative gene of autosomal recessive juvenile parkinsonism (ARJP), is of a special interest because it encodes an ubiquitin-protein ligase, which covalently attaches ubiquitin to target proteins, designating them for destruction by the proteasome. This review summarizes recent studies on the UPS pathway with a special reference to parkin, focusing on how parkin is linked to the pathogenesis of ARJP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571819     DOI: 10.1016/j.bbamcr.2004.09.026

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  36 in total

1.  Mechanism of polyubiquitin chain recognition by the human ubiquitin conjugating enzyme Ube2g2.

Authors:  William E Bocik; Aroop Sircar; Jeffrey J Gray; Joel R Tolman
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  The endoplasmic reticulum-associated degradation is necessary for plant salt tolerance.

Authors:  Lijing Liu; Feng Cui; Qingliang Li; Bojiao Yin; Huawei Zhang; Baoying Lin; Yaorong Wu; Ran Xia; Sanyuan Tang; Qi Xie
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

3.  Small-molecule agonists and antagonists of F-box protein-substrate interactions in auxin perception and signaling.

Authors:  Ken-Ichiro Hayashi; Xu Tan; Ning Zheng; Tatsuya Hatate; Yoshio Kimura; Stefan Kepinski; Hiroshi Nozaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

Review 4.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

5.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

6.  PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

Authors:  Joo-Ho Shin; Han Seok Ko; Hochul Kang; Yunjong Lee; Yun-Il Lee; Olga Pletinkova; Juan C Troconso; Valina L Dawson; Ted M Dawson
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy.

Authors:  Jie Li; Wei Qi; Guo Chen; Du Feng; Jinhua Liu; Biao Ma; Changqian Zhou; Chenglong Mu; Weilin Zhang; Quan Chen; Yushan Zhu
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

8.  The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity.

Authors:  Erin A Kimbrel; Andrew L Kung
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

9.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

10.  A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system.

Authors:  Sjoerd J L van Wijk; Sjoerd J de Vries; Patrick Kemmeren; Anding Huang; Rolf Boelens; Alexandre M J J Bonvin; H Th Marc Timmers
Journal:  Mol Syst Biol       Date:  2009-08-18       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.